Original Scientific Article THE EFFECT OF METOCLOPRAMIDE ON THE ANTINOCICEPTIVE, LOCOMOTOR AND NEUROBEHAVIORAL EFFECTS OF METAMIZOLE IN MICE Combining analgesic medications with distinct pharmacodynamics may result in effective analgesia and reduced adverse effects by lowering dosages of one or both medications. The objective was to investigate the nature of interactions of metoclopramide and metamizole by measuring the antinociceptive and neurobehavioral effects in mice. The drugs were administered intraperitoneally (ip) in mice. The antinociceptive effect was determined by the up-and-down method. Isobolographic analysis was performed by simultaneous injection of the two drugs at ED50 ratios of 1:1 and 0.5:0.5. The treated mice were also subjected to an open-field behavioral test as well as dorsal immobility and negative geotaxis behavioral paradigms. The ED50 of metoclopramide and metamizole were 33.71 and 43 mg/kg ip, respectively. Lower ED50 was established for metoclopramide and metamizole by 48.44% and 47.49%, respectively when given at a ratio of 0.5:0.5, and by 35.81% and 29.88%, respectively at a ratio of 1:1. The combined dose of metoclopramide and metamizole (8 and 10 mg/kg, ip, respectively) significantly decreased the open field-activity test in mice. This was observed by lower number of squares crossing compared to the control. Additionally, the drug combination resulted in a substantial increase in the duration of dorsal immobility response and delayed the negative geotaxis task when compared with the control group. The results indicated that the interaction between metoclopramide and metamizole in lower dose ratio with ED50 50:50, was synergistic in producing analgesia in mice with reduced risk for adverse reaction but with decreased behavioral and motor neuronal activity. https://macvetrev.mk/LoadArticlePdf/361 2024-10-15 159 166 https://doi.org/10.2478/macvetrev-2024-0027 metoclopramide metamizole antinociceptive effect neurobehavioral hot plate Zena Sattam Hamed zenasattam@uomosul.edu.iq false 1 Pharmacology and Toxicology Department, College of Pharmacy, University of Mosul, Iraq LEAD_AUTHOR Khalid Ahmed Shaban false 2 Physiology, Biochemistry and Pharmacology Department, College of Veterinary Medicine, University of Mosul, Iraq AUTHOR Ghada Abdul-Munem Faris false 3 Physiology, Biochemistry and Pharmacology Department, College of Veterinary Medicine, University of Mosul, Iraq AUTHOR Lee, A., Kuo, B. (2010). Metoclopramide in the treatment of diabetic gastroparesis.Expert Rev Endocrinol Metab. 5(5): 653-662. PMid:21278804 PMCid:PMC3027056 1 https://doi.org/10.1586/eem.10.41 Tavakoli, A., Mehrjerdi, H.K., Haghighi, A. (2009). Analgesic effects of metoclopramide following conventional ovariohysterectomy in bitches. Iranian J of Vet Sur. 4(1-2): 77-84. 2 Katzung, B.G. (2012). Basic and clinical pharmacology,12th ed. New York: McGraw-Hill 3 Harada, T., Hirosawa, T., Morinaga, K., Shimizu, T. (2017). Metoclopramide -induced serotonin syndrome. Intern Med. 56, 737- 739. PMid:28321081 PMCid:PMC5410491 4 https://doi.org/10.2169/internalmedicine.56.7727 Donald, C.P., Pharm, D. (2005). Veterinary drug handbook, 5th Ed. South State Avenue, Ames, Iowa: Blackwell Publishing Professional 5 Pang, W., Liu, Y.C., Maboudou, E., Chen, T.X., Chois, J.M., Liao, C.C., Wu, R.S. (2013). Metoclopramide improves the quality of tramadol PCA indistinguishable to morphine PCA: a prospective, randomized, double blind clinical comparison. Pain Med. 14(9): 1426-1434. PMid:23789747 6 https://doi.org/10.1111/pme.12166 Hamad, Z.S., Yahya, B.M. (2013). Identification and estimation of metoclopramide in rat blood by high performance liquid chromatography. Iraqi J Pharm. 13(1): 77-85. 7 https://doi.org/10.33899/iphr.2013.66908 Hofmeister, E.H., Egger, C.M. (2005). Evaluation of diphenhydramine as a sedative for dogs. J Am Vet Med Assoc. 226(7): 1092-1094. PMid:15825733 8 https://doi.org/10.2460/javma.2005.226.1092 Mohammad, F.K., Al-Baggou, B.K., Naser, A.S. (2012). Antinociception by metoclopramide, ketamine and their combinations in mice. Pharmacol Reports. 64(2): 299-304. PMid:22661179 9 https://doi.org/10.1016/S1734-1140(12)70768-5 Ai-Najmawy, T.A., Faris, G.M. (2018). Evaluation the antinociception of metoclopramide and their interaction with diphenhydramine in acute model of pain in male mice. Basrah J Vet Res. 3(17): 391-411. 10 Shaban, K.A., Ibrahim, M.H., Faris, G.A. (2020). Evaluation of the antinociceptive effect of xylazine and it’ s interaction with metoclopramide in the acute pain model in mice. Iraqi J Vet Sci. 43(2): 383-388. 11 https://doi.org/10.33899/ijvs.2019.126070.1226 Miljković, M.N., Rančić, N.K., Simić, R.M., Stamenković, D.M., Dragojević-Simić, V.M. (2018). Metamizole: current status of the safety and efficacy. Hosp Pharm. 5(3): 694-704. 12 https://doi.org/10.5937/hpimj1803694M Leeuw, T.G., Dirckx, M., Gonzalez Candel, A., Scoones, G.P., Huygen, F.J.P.M., de Wildt, S.N. (2017). The use of dipyrone (metamizol) as an analgesic in children: what is the evidence? A review. Paediatr Anaesth. 27(12): 1193-1201. PMid:29024184 13 https://doi.org/10.1111/pan.13257 Chandrasekharan, N.V., Dai, H., Roos, K., Evanson, N.K., Tomsik, J., Elton, T., Simmons, D. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 99(21): 13926-13931. PMid:12242329 PMCid:PMC129799 14 https://doi.org/10.1073/pnas.162468699 Hernández-Delgadillo, G.P., Cruz, S.L. (2006). Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats. Eur J Pharmacol. 546(1-3): 54-59. PMid:16914138 15 https://doi.org/10.1016/j.ejphar.2006.07.027 Mohammad, F.K., Faris, G.A.M., Rayma, M.Sh. (2001). Analgesic and behavioral effects of xylazinedipyrone combination in mice. Iraqi J Vet Sci. 14, 183-189. 16 Ibrahem, K.A.S. (2013). The analgesic and neurobehavioral effects of dipyrone or tramadol and their interaction with xylazine in chicks model [Master Thesis]. University of Mosul, Mosul, Iraq 17 Bagheban, A.R., Nasiri, M., Majd, H.A., Shafaghi, B. (2010). Estimation of median effective dose of anti spasmodic medicine in adaptive design by combining the models. Koomesh. 11(3): 184-189. 18 Dixon, W.J. (1980). Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol. 20, 441-462. PMid:7387124 19 https://doi.org/10.1146/annurev.pa.20.040180.002301 Roy, R., Daula, A.S.U., Akter, A., Sultana, S., Barek, M.A., Liya, I.J., Basher, M.A. (2019). Antipyretic and leaves of Fimbristylis miliacea in mice model. J Ethnopharmacol. 243, 112080. PMid:31306693 20 https://doi.org/10.1016/j.jep.2019.112080 Puig, M.M., Pol, O., Warner, W. (1996). Interaction of morphine and clonidine on gastrointestinal transit in mice. Anesthesiology 85(6): 1403-1412. PMid:8968188 21 https://doi.org/10.1097/00000542-199612000-00022 Tallarida, R.J. (2002). The interaction index: a measure of drug synergism. Pain 98(1-2): 163-168. PMid:12098628 22 https://doi.org/10.1016/S0304-3959(02)00041-6 Molinengo, L., Fundarò, A., Orsetti, M. (1989). The effect of chronic atropine administration on mouse motility and on Ach levels in the central nervous system. Pharmacol Biochem Behav. 32(4): 1075-1077. PMid:2798531 23 https://doi.org/10.1016/0091-3057(89)90085-3 Tatem, K.S,, Quinn, J.L., Phadke, A., Yu, Q., Gordish-dressman, H., Nagaraju, K. (2014). Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J Vis Exp. 29(91): 51785. PMid:25286313 PMCid:PMC4672952 24 https://doi.org/10.3791/51785 Molloy, A.G., Aronstam, R.S., Buccafusco, J.J. (1986). Selective antagonism by clonidine of the stereotyped and non-stereotyped motor activity elicited by atropine. Pharmacol Biochem Behav. 25(5): 985-988. PMid:3786370 25 https://doi.org/10.1016/0091-3057(86)90074-2 Mohammad, F.K., St, V.O. (1986). Behavioral and developmental effects in rats following in utero exposure to 2, 4-D/2, 4, 5-t mixture. Neurobehav Toxicol Teratol. 8(5): 551-560. 26 Yoshida, S., Esposito, G., Ohnishi, R., Tsuneoka, Y., Okabe, S., Kikusui, T., et al. (2013). Transport response is a filial-specific behavioral response to maternal carrying in C57BL/6 mice. Front Zool. 10(1): 50. PMid:23945354 PMCid:PMC3751433 27 https://doi.org/10.1186/1742-9994-10-50 Petrie, A., Watson, P. (2013). Statistics for veterinary and animal science. John Wiley & Sons 28 Fisher, A.A., Davis, M.W. (2002). Serotonin syndrome caused by selective serotonin reuptakeinhibitors metoclopramide interaction. Ann Pharmacother. 36(1): 67-71. PMid:11816261 29 https://doi.org/10.1345/aph.1A161 Ozucelik, D.N., Karaca, M.A., Sivri, B. (2005). Effectiveness of pre‐emptive metoclopramide infusion in alleviating pain, discomfort and nausea associated with nasogastric tube insertion: a randomized, double-blind, placebo-controlled trial. Int J Clin Pract. 59(12): 1422-1427.PMid:16351674 30 https://doi.org/10.1111/j.1368-5031.2005.00712.x Alves, D.P., Duarte, I.D.G. (2002). Involvement of ATP-sensitive K+ channels in the peripheral antinociceptive effect induced by dipyrone. Eur J Pharmacol. 444(1-2): 47-52. PMid:12191581 31 https://doi.org/10.1016/S0014-2999(02)01412-7 Hernández, N., Vanegas, H. (2001). Antinociception induced by PAG-microinjected dipyrone (metamizol) in rats: involvement of spinal endogenous opioids. Brain Res. 896(1-2): 175-178. PMid:11277989 32 https://doi.org/10.1016/S0006-8993(01)02085-6 Silva-Moreno, A., López-Muñoz, F.J., Cruz, S.L. (2009). D-propoxyphene and dipyrone coadministration produces greater antinociception and fewer adverse effects than single treatments in rats. Eur J Pharmacol [Internet]. 607(1-3): 84-90. PMid:19232342 33 https://doi.org/10.1016/j.ejphar.2009.02.010 Hedenmalm, K., Spigset, O. (2002). Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 58(4): 265-274. PMid:12136373 34 https://doi.org/10.1007/s00228-002-0465-2 Gould, S., Fulton, R., Koller, D. (2009). Decomposing a scene into geometric and semantically consistent regions. Proceedings of IEEE Int Conf Comput Vis. 1-8. 35 https://doi.org/10.1109/ICCV.2009.5459211 Botting, R., Ayoub, S. (2005). COX-3 and the mechanism of action of paracetamol/ acetaminophen. Prostaglandins Leukot Essent Fatty Acids. 72(2): 85-87. PMid:15626590 36 https://doi.org/10.1016/j.plefa.2004.10.005 Rang, H.P., Dale, M.M., Ritter, J.M., Moore, P.K.(2003). Pharmacology 5th Ed. Edinburgh: Churchill Livingstone 37